Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Inherited cardiac arrhythmias are a group of genetic diseases predisposing to sudden cardiac arrest, mainly resulting from variants in genes encoding cardiac ion channels or proteins involved in their regulation. Currently available therapeutic options (pharmacotherapy, ablative therapy and device-based therapy) can not preclude the occurrence of arrhythmia events and/or provide complete protection. With growing understanding of the genetic background and molecular mechanisms of inherited cardiac arrhythmias, advancing insight of stem cell technology, and development of vectors and delivery strategies, gene therapy and stem cell therapy may be promising approaches for treatment of inherited cardiac arrhythmias. Recent years have witnessed impressive progress in the basic science aspects and there is a clear and urgent need to be translated into the clinical management of arrhythmic events. In this review, we present a succinct overview of gene and cell therapy strategies, and summarize the current status of gene and cell therapy. Finally, we discuss future directions for implementation of gene and cell therapy in the therapy of inherited cardiac arrhythmias. Copyright © 2024. Published by Elsevier Inc.


Zhong-He Zhang, Hector Barajas-Martinez, Hong Jiang, Cong-Xin Huang, Charles Antzelevitch, Hao Xia, Dan Hu. Gene and stem cell therapy for inherited cardiac arrhythmias. Pharmacology & therapeutics. 2024 Apr;256:108596

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 38301770

View Full Text